Literature DB >> 27306300

Management of fibromyalgia syndrome in 2016.

Akiko Okifuji1, Jeff Gao1, Christina Bokat1, Bradford D Hare1.   

Abstract

Fibromyalgia syndrome is a chronic pain disorder and defies definitively efficacious therapy. In this review, we summarize the results from the early treatment research as well as recent research evaluating the pharmacological, interventional and nonpharmacological therapies. We further discuss future directions of fibromyalgia syndrome management; we specifically focus on the issues that are associated with currently available treatments, such as the need for personalized approach, new technologically oriented and interventional treatments, the importance of understanding and harnessing placebo effects and enhancement of patient engagement in therapy.

Entities:  

Keywords:  exercise; fibromyalgia; interventional treatment; multidisciplinary therapy; pharmacological treatment; placebo; treatment engagement

Mesh:

Year:  2016        PMID: 27306300      PMCID: PMC5066139          DOI: 10.2217/pmt-2016-0006

Source DB:  PubMed          Journal:  Pain Manag        ISSN: 1758-1869


  169 in total

1.  The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada.

Authors:  K P White; M Speechley; M Harth; T Ostbye
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  Antidepressant treatment of fibromyalgia. A meta-analysis and review.

Authors:  L M Arnold; P E Keck; J A Welge
Journal:  Psychosomatics       Date:  2000 Mar-Apr       Impact factor: 2.386

3.  Determinants of physical activity initiation and maintenance among community-dwelling older persons.

Authors:  L C Burton; S Shapiro; P S German
Journal:  Prev Med       Date:  1999-11       Impact factor: 4.018

4.  Effects of short versus long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial.

Authors:  Candice L Schachter; Angela J Busch; Paul M Peloso; M Suzanne Sheppard
Journal:  Phys Ther       Date:  2003-04

5.  Effects of a 1.5-day multidisciplinary outpatient treatment program for fibromyalgia: a pilot study.

Authors:  Angela Pfeiffer; Jeffrey M Thompson; Audrey Nelson; Sharon Tucker; Connie Luedtke; Steve Finnie; Chris Sletten; John Postier
Journal:  Am J Phys Med Rehabil       Date:  2003-03       Impact factor: 2.159

6.  The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.

Authors:  Martin B Scharf; Margaret Baumann; David V Berkowitz
Journal:  J Rheumatol       Date:  2003-05       Impact factor: 4.666

7.  Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial.

Authors:  Selwyn C M Richards; David L Scott
Journal:  BMJ       Date:  2002-07-27

8.  Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study.

Authors:  Robert M Bennett; Marc Kamin; Rezaul Karim; Norman Rosenthal
Journal:  Am J Med       Date:  2003-05       Impact factor: 4.965

9.  Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia.

Authors:  Richard H Gracely; Frank Petzke; Julie M Wolf; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2002-05

10.  Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndrome.

Authors:  J H Raphael; J L Southall; G J Treharne; G D Kitas
Journal:  BMC Musculoskelet Disord       Date:  2002-09-08       Impact factor: 2.362

View more
  13 in total

1.  Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis.

Authors:  Filippo Migliorini; Nicola Maffulli; Matthias Knobe; Giacomo Tenze; Ali Aljalloud; Giorgia Colarossi
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

Review 2.  Cannabis for Rheumatic Disease Pain: a Review of Current Literature.

Authors:  William Benjamin Nowell; Kelly Gavigan; Stuart L Silverman
Journal:  Curr Rheumatol Rep       Date:  2022-04-29       Impact factor: 4.686

3.  Translating Outcomes from the Clinical Setting to Preclinical Models: Chronic Pain and Functionality in Chronic Musculoskeletal Pain.

Authors:  Melissa E Lenert; Rachelle Gomez; Brandon T Lane; Dana L Dailey; Carol G T Vance; Barbara A Rakel; Leslie J Crofford; Kathleen A Sluka; Ericka N Merriwether; Michael D Burton
Journal:  Pain Med       Date:  2022-09-30       Impact factor: 3.637

Review 4.  Magnesium and Pain.

Authors:  Hyun-Jung Shin; Hyo-Seok Na; Sang-Hwan Do
Journal:  Nutrients       Date:  2020-07-23       Impact factor: 5.717

5.  Diagnostic and therapeutic challenge - fibromyalgia.

Authors:  Brygida Kwiatkowska; Howard Amital
Journal:  Reumatologia       Date:  2018-10-31

6.  Attenuation of reserpine-induced fibromyalgia via ROS and serotonergic pathway modulation by fisetin, a plant flavonoid polyphenol.

Authors:  Xianli Yao; Li Li; Amit D Kandhare; Anwesha A Mukherjee-Kandhare; Subhash L Bodhankar
Journal:  Exp Ther Med       Date:  2019-12-13       Impact factor: 2.447

7.  Serotonergic Neurotransmission System Modulator, Vortioxetine, and Dopaminergic D2/D3 Receptor Agonist, Ropinirole, Attenuate Fibromyalgia-Like Symptoms in Mice.

Authors:  Kinga Sałat; Anna Furgała-Wojas
Journal:  Molecules       Date:  2021-04-20       Impact factor: 4.411

8.  Learning from our mistakes.

Authors:  Manfred Harth
Journal:  Can J Pain       Date:  2017-10-23

9.  Use of Dietary Supplements and Perceived Knowledge among Adults Living with Fibromyalgia in Norway: A Cross-Sectional Study.

Authors:  Linda Aimée Hartford Kvæl; Ida Løchting; Marianne Molin
Journal:  Nutrients       Date:  2021-12-21       Impact factor: 5.717

10.  Dietary Interventions in the Management of Fibromyalgia: A Systematic Review and Best-Evidence Synthesis.

Authors:  Ethan Lowry; Joanne Marley; Joseph G McVeigh; Emeir McSorley; Philip Allsopp; Daniel Kerr
Journal:  Nutrients       Date:  2020-08-31       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.